Your browser is no longer supported. Please, upgrade your browser.
BASI Bioanalytical Systems, Inc. monthly Stock Chart
BASI [NASD]
Bioanalytical Systems, Inc.
Index- P/E- EPS (ttm)-0.24 Insider Own8.20% Shs Outstand10.91M Perf Week9.57%
Market Cap78.10M Forward P/E- EPS next Y- Insider Trans1.30% Shs Float7.19M Perf Month34.47%
Income-2.60M PEG- EPS next Q- Inst Own10.80% Short Float0.07% Perf Quarter46.39%
Sales59.50M P/S1.31 EPS this Y-244.00% Inst Trans-6.24% Short Ratio0.17 Perf Half Y40.04%
Book/sh0.84 P/B8.45 EPS next Y- ROA-4.60% Target Price- Perf Year53.02%
Cash/sh0.26 P/C26.93 EPS next 5Y- ROE-26.00% 52W Range3.05 - 7.10 Perf YTD43.43%
Dividend- P/FCF- EPS past 5Y10.80% ROI-0.60% 52W High0.00% Beta1.75
Dividend %- Quick Ratio0.50 Sales past 5Y12.10% Gross Margin31.00% 52W Low132.79% ATR0.25
Employees150 Current Ratio0.60 Sales Q/Q45.00% Oper. Margin-2.00% RSI (14)82.85 Volatility3.22% 4.77%
OptionableNo Debt/Eq3.50 EPS Q/Q-98.40% Profit Margin-4.40% Rel Volume1.31 Prev Close7.06
ShortableYes LT Debt/Eq2.30 Earnings- Payout- Avg Volume29.11K Price7.10
Recom- SMA2015.95% SMA5029.34% SMA20045.65% Volume38,082 Change0.57%
Oct-20-11Initiated Ladenburg Thalmann Buy $3.75
Oct-20-20 08:33AM  
Sep-09-20 08:33AM  
Aug-21-20 10:07AM  
Aug-14-20 08:33AM  
Aug-11-20 08:33AM  
May-23-20 08:34AM  
May-14-20 08:33AM  
08:33AM  
May-05-20 08:33AM  
Apr-24-20 04:05PM  
Apr-22-20 12:21PM  
Apr-21-20 06:43AM  
Mar-11-20 03:15PM  
Mar-09-20 04:45PM  
Feb-21-20 05:38AM  
Feb-14-20 08:33AM  
Feb-12-20 09:18AM  
Feb-03-20 05:59AM  
Dec-23-19 10:03AM  
Dec-03-19 08:37AM  
Nov-14-19 08:33AM  
Nov-08-19 03:00PM  
Nov-05-19 05:22AM  
Oct-01-19 08:33AM  
Sep-29-19 09:07AM  
Sep-04-19 08:33AM  
Aug-15-19 12:38PM  
Aug-14-19 08:33AM  
Aug-07-19 08:33AM  
Jun-19-19 03:11PM  
May-21-19 08:53AM  
May-15-19 08:33AM  
May-10-19 08:33AM  
May-07-19 02:30PM  
May-01-19 09:30AM  
Apr-22-19 03:54PM  
Mar-08-19 01:07PM  
Mar-07-19 08:33AM  
Feb-21-19 09:23AM  
Feb-15-19 08:03AM  
Feb-14-19 08:03AM  
Feb-12-19 11:52AM  
Jan-16-19 08:33AM  
Dec-20-18 08:03AM  
Dec-18-18 02:03PM  
Nov-16-18 11:12AM  
Nov-01-18 08:43AM  
Oct-17-18 08:33AM  
Aug-24-18 11:29AM  
Aug-14-18 08:33AM  
Aug-08-18 08:33AM  
Jul-09-18 09:00AM  
Jul-02-18 09:00AM  
Jun-27-18 10:43AM  
May-25-18 04:57PM  
May-15-18 08:33AM  
May-10-18 08:33AM  
Apr-30-18 02:37PM  
Apr-04-18 08:25AM  
Mar-27-18 08:15AM  
Mar-08-18 12:03PM  
Feb-14-18 03:59PM  
Feb-13-18 07:00AM  
Feb-12-18 11:36AM  
Feb-08-18 11:15AM  
Jan-23-18 07:03PM  
Jan-02-18 01:59PM  
Dec-26-17 08:40AM  
Dec-22-17 04:48PM  
Dec-19-17 08:35AM  
Dec-15-17 02:00PM  
Dec-12-17 08:33AM  
Nov-21-17 09:59AM  
Nov-13-17 08:33AM  
Oct-03-17 08:17AM  
Sep-22-17 01:06PM  
Sep-06-17 08:17AM  
Aug-22-17 07:00AM  
Aug-16-17 12:10PM  
Aug-14-17 08:30AM  
Aug-03-17 08:33AM  
Jul-31-17 08:03AM  
Jun-27-17 09:00AM  
Jun-07-17 10:09AM  
May-24-17 09:50AM  
May-15-17 08:30AM  
May-10-17 01:00PM  
May-01-17 11:42AM  
Mar-16-17 08:34AM  
Mar-13-17 01:44PM  
Mar-08-17 02:12PM  
Feb-18-17 01:04PM  
Feb-14-17 02:07PM  
08:30AM  
07:07AM  
Feb-13-17 08:33AM  
Feb-01-17 01:44PM  
Jan-17-17 11:45AM  
07:59AM  
Dec-30-16 09:01AM  
Bioanalytical Systems, Inc., doing business as Inotiv, a pharmaceutical development company, provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment also provides in vivo sampling services for the continuous monitoring of chemical changes in life; non-clinical toxicology and pathology services; analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sagartz John EChief Strategy OfficerAug 19Buy4.753,73317,732634,232Aug 20 04:02 PM
Neff R MatthewDirectorAug 19Buy4.755,00023,75060,350Aug 19 04:27 PM
Leasure Robert Jr.President and CEOJun 15Buy5.202,88414,997186,549Jun 16 04:08 PM
Pitchford William DChief HR OfficerMay 21Buy4.4710,00044,70032,000May 22 04:02 PM
Taylor BethVP- Finance & CFOMay 21Buy4.523,30014,91613,300May 21 07:13 PM
Taylor BethVP- Finance & CFOMay 20Buy4.424,93321,80410,000May 21 07:13 PM
Taylor BethVP- Finance & CFOMay 19Buy4.385,06722,1935,067May 21 07:13 PM
Leasure Robert Jr.President and CEOMar 16Buy3.495,70019,893183,665Mar 17 04:01 PM
Neff R MatthewDirectorMar 13Buy3.933,35013,16645,350Mar 16 04:04 PM
Neff R MatthewDirectorMar 12Buy3.8012,00045,60042,000Mar 16 04:04 PM
Johnson Richard AllenDirectorFeb 20Buy4.6320,00092,60030,000Feb 20 04:06 PM
Neff R MatthewDirectorFeb 20Buy4.609,45843,50730,000Feb 21 04:03 PM